MCA
RMD icon

Maryland Capital Advisors’s ResMed RMD Stock Holding History

Maryland Capital Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$195 Buy
+1
New +$207 ﹤0.01% 455
2025
Q3 		– Sell
-47
Closed -$12.1K – 275
2025
Q2 		$12.1K Buy
+47
New +$11.2K ﹤0.01% 184

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Maryland Capital Advisors's RMD Position: Q2 2026 in Review

Maryland Capital Advisors opened a new position in ResMed (RMD) in Q2 2026: 1 share worth $195. The stake represents ﹤0.01% of the portfolio and ranks #455 among its holdings. This is a return to the name: Maryland Capital Advisors previously reported a position in RMD as recently as Q2 2025.

Maryland Capital Advisors first reported a position in RMD in Q2 2025 and has held it in 2 quarters since. The position peaked at $12.1K in Q2 2025. 448 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Maryland Capital Advisors held 1 share of ResMed worth $195 as of Q2 2026.
  • ResMed was a new Maryland Capital Advisors position in Q2 2026.
  • ResMed made up ﹤0.01% of Maryland Capital Advisors's portfolio in Q2 2026, its #455 holding.
  • Maryland Capital Advisors first reported a position in ResMed in Q2 2025 and has held it in 2 quarters since.
  • Maryland Capital Advisors's ResMed position peaked at $12.1K in Q2 2025.
  • 448 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Maryland Capital Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.